Top best Federal Regulation Lawyers in Washington | 41 available
41 Federal Regulation lawyers are available in Washington, Virginia. These lawyers are rated between 4.8/5 to 5/5 and 59% provide free consultation with fees ranging from $47 to $70 per hour.
24 - 41
$217 - $480
47% - 70%
4.8 - 5.0 ★
FAQs - Federal Regulation Lawyers in city Washington How many Federal Regulation lawyers actively serve residents of Washington, District Of Columbia? Approximately 21 licensed attorneys focus on Federal Regulation across Washington, District Of Columbia. Most matters are filed through the District Of Columbia District Court, where local rules shape timelines and filing steps. What is the typical hourly fee for Federal Regulation lawyers in Washington, District Of Columbia? In Washington, typical rates range from $210-$429 per hour for Federal Regulation. End-to-end case budgets frequently land between $3933 and $7062, depending on hearings and discovery. How long do Federal Regulation matters usually take in courts near Washington? Federal Regulation cases in Washington, District Of Columbia usually take around 4-12 months depending on complexity and the District Of Columbia District Court docket. Which local court most often hears Federal Regulation cases for people living in Washington, District Of Columbia? Residents of Washington typically see Federal Regulation filings handled by the District Of Columbia District Court. Proximity to helps with quick submissions and clerk communications. Do attorneys around offer a free first consultation for Federal Regulation? About 53% of firms near ZIP offer a free first consultation for Federal Regulation, so you can compare strategy and fit before committing.
41 Federal Regulation Lawyers Found Near You
We assist companies in need of counsel or seeking to grow their businesses by providing legal and strategy advisory services in several core areas: international trade regulatory compliance, regulatory/legislative advocacy, commercial transactions and international operations. We counsel clients on devising and implementing strategies to achieve their business objectives and overcome the commercial, regulatory, political and cultural obstacles they face.. Don has practiced regulatory and commercial law as senior counsel to Akin Gump Strauss Hauer & Feld in Washington and as international legal advisor to Kim & Chang in Seoul, Korea. For more than a decade, he has advised US and overseas companies on developing and executing strategies to seize new business opportunities while mitigating market and political risks. He currently serves as Of Counsel to Washington Global Law Group and as Senior Advisor to Albright Stonebridge Group.. Don is committed to public service and has held a number of senior federal government positions. He served as Senior Advisor to the Under Secretary for International Security Affairs in the U.S. State Department, as Counselor of the U.S. Arms Control and Disarmament Agency, and as Director of Legislative affairs at the White House National Security Council.. Over the years, Don has published numerous articles on business, legal and public policy issues, while serving as a commentator for CNN, MSNBC, Fox Business News, SkyNews, the Voice of America, the Wall Street Journal and other leading media. In 2013, Bloomsbury published his critically acclaimed book on U.S.-China relations titled "The China Fallacy: How the U.S. Can Benefit from China's Rise and Avoid Another Cold War.". Don is an arbitrator for the Office of Dispute Resolution of the Financial Industry Regulatory Authority (FINRA) and an Adjunct Fellow of Pacific Forum CSIS, an arm of the Center for Strategic and International Studies. He has been admitted to the Bar of the District of Columbia, New York and Illinois. He graduated with honors from Cornell University and the University of Chicago Law School. In his spare time, Don enjoys practicing Tae Chi, hiking the Shenandoah with his wife Sue, a professional artist, and playing with his canine BFFs, Ralphie and Sally.
Mr. Ferrari’s main areas of practice are assisting clients to comply with and address issues related to U.S. economic sanctions. In this capacity he works extensively on issues arising before the U.S. Department of Treasury Office of Foreign Assets Control (“OFAC”).. OFAC Representation. In his OFAC practice, Mr. Ferrari represents both private individuals and entities in various parts of the U.S. and in numerous countries around the world.. Mr. Ferrari’s representations before OFAC frequently involve licensing matters and investigations concerning the Iranian Transactions and Sanctions Regulations, the Cuban Assets Control Regulations, and the Narcotics Trafficking Sanctions Regulations. As part of these representations, Mr. Ferrari has worked to have individuals' names removed from OFAC’s Specially Designated Nationals list, answer administrative subpoenas issued during the course of an OFAC investigation, procured OFAC specific licenses to engage in transactions prohibited by OFAC regulations, drafted voluntary self-disclosures to report OFAC violations, developed and implemented OFAC compliance programs for international trade companies, and provided general counseling on OFAC related issues.. Mr. Ferrari actively writes on OFAC administered trade sanctions and has been published on the matter. In addition, he is often called upon by media outlets to speak on U.S. trade sanctions issues. He has been interviewed on OFAC related issues by CNN, Time Magazine, the Wall Street Journal, the New York Times, and the BBC. He is the founder and author of a U.S. economic sanctions blog: .. Civil Litigation. Mr. Ferrari also has served as lead counsel in a number of civil litgation matters involving the federal government. Most notably, he has been involved in lawsuits against OFAC for SDN Reconsiderations, and for blocking of assets due to U.S. economic sanctions programs. These representations include federal appeals of OFAC SDN designations under the Foreign Narcotics Kingpin Designation Act. In addition, he has represented parties whose assets have been seized for forfeiture in part because of their alleged connection to parties on the OFAC SDN List.. Federal Criminal Defense. Mr. Ferrari has served as lead trial counsel on a number of complex federal white collar defense cases. He is a seasoned litigator and also has a masterful understanding of both pre-trial and post-trial procedures.. Amongst other matters, Mr. Ferrari has successfully handled:. 1. IEEPA (sanctions) Criminal Cases. 2. Mail and Wire Fraud Cases. 3. Export Control Violaitons under the Arms Control Export Act. 4. Tax fraud. 5. Money laundering. 6. Drug trafficking/importation. 7. Public corruption. 8. Federal Appeals. Mr. Ferrari has handled matters throughout the United States, including Maryland, New York, Texas, North Dakota, Florida, California, Virginia and Washington D.C. He also assists clients in Africa, Europe, the Middle East and Central and South America.. Bar Admissions and Associations. District of Columbia. District of Columbia Circuit Court of Appeals. 4th Circuit Court of Appeals. 5th Circuit Court of Appeals. 11th Circuit Court of Appeals. United States District Court for the District of Columbia. United States District Court for the Northern District of Florida. United States District Court for the Southern District of Texas. United States District Court for the District of North Dakota. Iranian American Bar Association-National Board of Directors (former)
Mason devotes his practice to a blend of regulatory and litigation matters, principally representing medical device, biologics, pharmaceutical and food manufacturers, distributors and importers.. Mason advises clients on a wide array of topics ranging from approval and compliance of products regulated by the U.S. Food and Drug Administration to compliance with the complexities of the Health Insurance Portability and Accountability Act (HIPAA). Mason assists clients with import issues involving FDA regulated products, including import holds, detentions, and refusals. Consistent with his Food, Drug and Medical Device practice, Mason also provides regulatory due diligence opinions to financial institutions and other companies that may consider the purchase of a FDA regulated entity. In addition to the above, Mason provides his trade association clients with legislative and regulatory development updates, and counsel on governance and antitrust issues.. Mason has a dynamic background that includes litigation and sales and marketing experience. This affords him a unique and beneficial perspective in assessing and resolving regulatory matters. Mason previously worked in sales and marketing for a biologics manufacturer and a laboratory that provided neurogenetic diagnostic testing. After graduating from law school, Mason was law clerk to The Honorable Terrence J. McGann, of the Circuit Court for Montgomery County, Maryland, where he was provided with vast exposure to litigation. He then specialized in civil litigation at a boutique law firm in Maryland before joining OFW Law.. Mason was voted by his peers as a SuperLawyers “Rising Star” in Washington, DC and Maryland for 2013, 2014 and 2015. He was also recognized by Martindale Hubble with the "Client Distinction Award" in 2012.. Mason was born and raised in the Washington, D.C., metropolitan area. He is a graduate of Gonzaga College High School in Washington, DC. He later received his Bachelor of Arts degree in English from Fairfield University in 2001, and his Juris Doctor from the University of Baltimore in 2009. Mason is a member of the Health, Agriculture Law Sections of the Maryland State Bar Association, the Food and Drug Law Institute and the American Health Lawyers Association.
I am Managing Partner at Ubias Law, PLLC. I advise emerging and growth companies with an international footprint on compliance with trade and investment activities subject to US laws. I counsel small business seeking federal government contracts and advise on compliance requirements. I also counsel and collaborate with companies working with distributed ledger technology, cryptocurrencies and digital asset management blockchain solutions to navigate the patchwork of regulations and evolving guidance from the regulators and the requirements of evolving legislation. My practice also includes advising public and private companies in navigating compliance and due diligence issues in capital market transactions and e-discovery consulting and subpoena responses.
H. Paul Moon is a filmmaker, composer and video artist. Through his production company Zen Violence Films, he profiles performing and visual artists who span boundaries from classical arts to new media technologies. He also creates experimental films in the tradition of wordless environmental cinema ranging from city symphonies to "Koyaanisqatsi."Moon's debut film "El Toro" — an experimental work that explores connections between the ancient ritual of Spanish bullfights, and the passion of the Christ — won the Best of Show award of the 2010 Rosebud Film & Video Festival at Artisphere, and the Experimental Media Prize of the 2011 WPA Experimental Media Series at The Phillips Collection. Prior to "El Toro," Moon filmed the documentary "R. Luke DuBois: Running Out of Time," profiling a New York composer and visual artist who builds on notions of cultural and romantic memory, exploring how information can be time-manipulated for emotional impact. The documentary premiered at the 2011 DC Independent Film Festival, won the 2011 "Best Short Documentary" jury prize at the Chicago International Movies & Music Festival, won the 2011 "Silver Medal for Excellence in a Music Documentary" at the Park City Film Music Festival, and won the 2013 "Best Short Film" jury prize at the Reel Indie Film Fest in Toronto. Subsequently, Moon filmed the short documentary "Hamac Cazíim," about a punk band using music to maintain their indigenous heritage, which became an official selection at the Red Nation, Chicago International Movies & Music, Ruby Mountain and Indie Fest USA Film Festivals, the Native American Indian Film Festival of the Southeast, the Indianer Inuit: Das Nordamerika Filmfestival in Stuttgart, Germany, and XEPE AN CÖICOOS in Sonora, Mexico.Moon later debuted "Time Crunch," a landscape/environmental film accompaniment to the same-named work for chamber orchestra by composer Jordan Kuspa, at the Smithsonian American Art Museum with the 21st Century Consort. "Time Crunch" became an official selection at the Ruby Mountain, James River Shorts, Chronos, Park City Film Music, and Imagine Science Film Festivals. From the same series at the Smithsonian, he debuted an experimental work named "Simple Machines" with an original music score by R. Luke DuBois, which subsequently screened at the Virginia Museum of Fine Arts in Richmond, the Imagine Science Film Festival in New York City, and IFFEST in Bucharest, Romania. While prolifically creating shorts, his newest other films are "LowerTown Paducah," a feature-length documentary about an artist relocation program in Kentucky, and "The Saxon New World," a half-hour documentary about 19th-century Saxons who settled in rural Missouri, from the untold history of America's earliest and largest immigrations. Projects still in production include a narrative short, and five feature-length documentaries: about the American composer Samuel Barber, cowboy poetry, Fluxus art, the Occupy movement, and the life of Whittaker Chambers — an espionage thriller.Prior to his recent interest in filmmaking, Moon was a playwright and a composer of incidental music for theatre. He lives and works in the Washington, D.C. area, and manages online filmmaker communities at and . He is the recipient of the Emergence award at Docs In Progress, where he teaches video editing as an Adobe Certified Expert (A.C.E.).Samples are available through his online portfolio at .
Evan Phelps is a principal at OFW Law. He advises companies on compliance with Food and Drug Administration (FDA) law and regulations, with focus on matters related to medical devices and biologics as well as those affecting Clinical Investigators. This includes Assistance in the preparation of Premarket Approval Applications (PMAs), Premarket Notifications (510(k)s), and Investigational Device Exemption (IDE) Applications; Advice, training, and assistance with matters concerning the Quality System Regulation (QSR) and the Medical Device Reporting (MDR) Regulation; Assistance with responding to and resolving issues relating to: FDA establishment inspections, Forms FDA-483 (Inspectional Observations), Warning Letters, Recalls, Injunctions, Import/Export of FDA-regulated products, and Product labeling. Evan also assists in Clinical Investigators and IRBs with compliance, enforcement, and training issues. He advises companies on the impact of FDA law on business transactions and agreements; development of specially tailored plans to bring medical devices to market based upon client needs and goals; and assists in filing or responding to trade complaints.
David Rosen is a partner and public policy lawyer with Foley & Lardner LLP. Mr. Rosen has extensive experience in health law, life sciences, and food and drug regulation, including a range of Food and Drug Administration (FDA) regulatory issues affecting prescription and over-the-counter pharmaceuticals, medical devices and biologics. He is co-chair of the firm’s Life Sciences Industry Team and is also a member of the firm’s Government & Public Policy Practice and the Health Care and Food & Beverage Industry Teams.. Mr. Rosen was formerly a partner with two other law firms. He was also employed by the FDA for 14 years, progressing to various supervisory positions involving virtually all aspects related to the drug approval process, combination products, jurisdictional issues and related compliance activities.. Recognition. Mr. Rosen has been Peer Review Rated as AV® Preeminent™, the highest performance rating in Martindale-Hubbell's peer review rating system. In 2012 - 2015, The Legal 500 recognized Mr. Rosen for his work in life sciences. In 2015, he was named an IP Star by Managing Intellectual Property magazine. He has been a frequent speaker before national and international pharmaceutical industry associations on the ANDA submission and review process and on the IND and expedited drug development, review, and approval processes. Mr. Rosen has made presentations before investment analysts and managers of venture capital on the impact of FDA on the drug and biotech industry.. Affiliations. Mr. Rosen is a member of the University of Connecticut School of Pharmacy Advisory Board.. Education. Mr. Rosen earned his J.D. at The Catholic University of America, Columbus School of Law (1991). He also holds a Bachelor of Science degree from the University of Connecticut School of Pharmacy (1978).. Admissions. Mr. Rosen is admitted to practice in the District of Columbia and Maryland.. Publications